Does the Ethnic Difference Affect the Pharmacokinetics of Favipiravir? A Pharmacokinetic Study in Healthy EgyptianVolunteers and Development of Level C In-vitro In-vivo Correlation
Preprint
- 22 August 2022
- preprint
- Published by Springer Nature in Research Square
Abstract
Background and ObjectiveFavipiravir is an antiviral drug used to treat influenza. It is also being investigated for the treatment of a variety of other viral diseases, including SARS-CoV-2. Its pharmacokinetic profile varies depending on ethnic group. The present research examines the pharmacokinetic (Pk) features of favipiravir in healthy male Egyptian volunteers. Another goal of this research is to determine the optimum dissolution testing conditions for immediate release (IR) tablets.MethodsIn vitrodissolution testing was investigated for favipiravir tablet, Avigan®200 mg tablets, in three different pH media. The pharmacokinetic (Pk) features of favipiravir were examined in healthy male Egyptian volunteers. A newly developed and validated LC-MS/MS method was used to analyze real plasma samples of the healthy volunteers. Level Cin vitro in vivocorrelation (IVIVC) was developed to set the optimum dissolution medium to achieve accurate dissolution profile for favipiravir (IR) tablets.ResultsIn vitro dissolution results revealed significant difference among the three different dissolution media. The Pk parameters of twenty-seven human subjects showed mean value of Cpmaxof 5966.45ng/mL at median tmaxof 0.75 h with AUC0-∞equals 13325.54 ng.h/mL, showing half-life of 1.25 h. AUC0-tvs. % dissolved was used to develop level C IVIVC for favipiravir (IR) tablets.ConclusionsWhen compared to American and Caucasian volunteers, Egyptian participants had comparable Pk values, however they were considerably different from Japanese subjects. Phosphate buffer medium (pH 6.8) was found to be the optimum dissolution medium for in vitro dissolution testing for Favipiravir IR tablets.Keywords
All Related Versions
This publication has 31 references indexed in Scilit:
- The coefficient of determinationR2and intra-class correlation coefficient from generalized linear mixed-effects models revisited and expandedJournal of The Royal Society Interface, 2017
- One-Sample T-Test2017
- Ebola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy TrialsClinical Pharmacokinetics, 2016
- Development of In Vitro–In Vivo Correlation for Amorphous Solid Dispersion Immediate-Release Suvorexant Tablets and Application to Clinically Relevant Dissolution Specifications and In-Process ControlsJournal of Pharmaceutical Sciences, 2015
- Viruses and disease: emerging concepts for prevention, diagnosis and treatmentThe Journal of Pathology, 2014
- The use of Z-scores in paediatric cardiologyAnnals of Pediatric Cardiology, 2012
- Pharmacokinetics of Orally Administered Phenylbutazone in African and Asian Elephants (Loxodonta africana and Elephas maximus)Journal of Zoo and Wildlife Medicine, 2008
- Multiple level C in vitro/in vivo correlation of dissolution profiles of two l-thyroxine tablets with pharmacokinetics data obtained from patients treated for hypothyroidismEuropean Journal of Pharmaceutical Sciences, 2004
- In vitro–in vivo correlation (IVIVC) models for metformin after administration of modified‐release (MR) oral dosage forms to healthy human volunteersJournal of Pharmaceutical Sciences, 2001
- In vitro/in vivo correlations of dissolution data of carbamazepine immediate release tablets with pharmacokinetic data obtained in healthy volunteersEuropean Journal of Pharmaceutics and Biopharmaceutics, 1999